Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality

References

• Digitalis Investigation GroupThe effect of digoxin on mortality and morbidity in patients with heart failureN Engl J Med199733685255339036306
   PubMed Web of Science ®Google Scholar
• VamosMErathJWHohnloserSHDigoxin-associated mortality: a systematic review and meta-analysis of the literatureEur Heart J201536281831183825939649
   PubMed Web of Science ®Google Scholar
• CorleySDEpsteinAEDiMarcoJPRelationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) StudyCirculation2004109121509151315007003
   PubMed Web of Science ®Google Scholar
• HallbergPLindbäckJLindahlBStenestrandUMelhusHRIKS-HIA groupDigoxin and mortality in atrial fibrillation: a prospective cohort studyEur J Clin Pharmacol2007631095997117684738
   PubMed Web of Science ®Google Scholar
• ShahMAvgil TsadokMJackeviciusCAEssebagVBehlouliHPiloteLRelation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with vs without heart failureAm J Cardiol2014114340140624950677
   PubMed Web of Science ®Google Scholar
• TurakhiaMPSantangeliPWinkelmayerWCIncreased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF studyJ Am Coll Cardiol201464766066825125296
   PubMed Web of Science ®Google Scholar
• OuyangAJLvYNZhongHLMeta-analysis of digoxin use and risk of mortality in patients with atrial fibrillationAm J Cardiol2015115790190625660972
   PubMed Web of Science ®Google Scholar
• WashamJBStevensSRLokhnyginaYDigoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)Lancet201538599852363237025749644
   PubMed Web of Science ®Google Scholar
• MadelaireCSchouMNelveg-KristensenKEUse of digoxin and risk of death or readmission for heart failure and sinus rhythm: a nationwide propensity score matched studyInt J Cardiol201622194495027441473
   PubMed Web of Science ®Google Scholar
• Al-KhateebMQureshiWTOdehRThe impact of digoxin on mortality in patients with chronic systolic heart failure: a propensity-matched cohort studyInt J Cardiol201722821421827865188
   PubMed Web of Science ®Google Scholar
• FribergLHammarNRosenqvistMDigoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF)Heart201096427528019710030
   PubMed Web of Science ®Google Scholar
• MulderBAVan VeldhuisenDJCrijnsHJDigoxin in patients with permanent atrial fibrillation: data from the RACE II studyHeart Rhythm20141191543155024924587
   PubMed Web of Science ®Google Scholar
• ZiffOJLaneDASamraMSafety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial dataBMJ2015351h445126321114
   PubMed Web of Science ®Google Scholar
• WyseDGWaldoALDiMarcoJPA comparison of rate control and rhythm control in patients with atrial fibrillationN Engl J Med2002347231825183312466506
   PubMed Web of Science ®Google Scholar
• WhitbeckMGCharnigoRJKhairyPIncreased mortality among patients taking digoxin – analysis from the AFFIRM studyEur Heart J201334201481148823186806
   PubMed Web of Science ®Google Scholar
• GheorghiadeMFonarowGCvan VeldhuisenDJLack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trialEur Heart J201334201489149723592708
   PubMed Web of Science ®Google Scholar
• van VeldhuisenDJVan GelderICAhmedAGheorghiadeMDigoxin for patients with atrial fibrillation and heart failure: paradise lost or not?Eur Heart J201334201468147023324547
   PubMed Web of Science ®Google Scholar
• MurphySAWhen ‘digoxin use’ is not the same as ‘digoxin use’: lessons from the AFFIRM trialEur Heart J201334201465146723592709
   PubMed Web of Science ®Google Scholar
• GoldbergerZDGoldbergerALTherapeutic ranges of serum digoxin concentrations in patients with heart failureAm J Cardiol2012109121818182122502901
   PubMed Web of Science ®Google Scholar
• KhanSSGheorghiadeMDigoxin use in atrial fibrillation: a critical reappraisalLancet201538599852330233225749645
   PubMed Web of Science ®Google Scholar
• LeviAJBoyettMRLeeCOThe cellular actions of digitalis glycosides on the heartProg Biophys Mol Biol19946211548085015
   PubMed Web of Science ®Google Scholar
• EichhornEJGheorghiadeMDigoxinProg Cardiovasc Dis200244425126612007081
   PubMed Web of Science ®Google Scholar
• LonghurstJCRossJJrExtracardiac and coronary vascular effects of digitalisJ Am Coll Cardiol198555 Suppl A99A105A
   PubMed Web of Science ®Google Scholar
• SombergJCDigitalis: neurally mediated arrhythmogenic and coronary vasoconstrictor propertiesJ Clin Pharmacol19852575295392866199
   PubMed Web of Science ®Google Scholar
• RiviniusRHelmschrottMRuhparwarAThe influence of surgical technique on early posttransplant atrial fibrillation – comparison of biatrial, bicaval, and total orthotopic heart transplantationTher Clin Risk Manag20171328729728331331
   PubMed Web of Science ®Google Scholar
• RiviniusRHelmschrottMRuhparwarAComparison of post-transplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantationDrug Des Devel Ther20171118271837
   PubMed Web of Science ®Google Scholar
• RiviniusRHelmschrottMRuhparwarALong-term use of amiodarone before heart transplantation reduces significantly early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantationDrug Des Devel Ther201610677686
   PubMed Web of Science ®Google Scholar
• RiviniusRHelmschrottMRuhparwarAAnalysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapyDrug Des Devel Ther2014993102
   PubMed Web of Science ®Google Scholar
• HelmschrottMRiviniusRRuhparwarAAdvantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantationDrug Des Devel Ther2015912171224
   PubMed Web of Science ®Google Scholar
• HelmschrottMRiviniusRBrucknerTKatusHADoeschAORenal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapyDrug Des Devel Ther20171116731680
   PubMed Web of Science ®Google Scholar
• SmithTWPharmacokinetics, bioavailability and serum levels of cardiac glycosidesJ Am Coll Cardiol198555 Suppl A43A50A
   PubMed Web of Science ®Google Scholar
• RathoreSSCurtisJPWangYBristowMRKrumholzHMAssociation of serum digoxin concentration and outcomes in patients with heart failureJAMA2003289787187812588271
   PubMed Web of Science ®Google Scholar
• HohnloserSHPajitnevDPogueJIncidence of stroke in paroxysmal vs sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W SubstudyJ Am Coll Cardiol200750222156216118036454
   PubMed Web of Science ®Google Scholar
• DasariTWPavlovic-SurjancevBPatelNIncidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantationAm J Cardiol2010106573774120723655
   PubMed Web of Science ®Google Scholar
• PavriBBO’NunainSSNewellJBRuskinJNWilliamGPrevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantationJ Am Coll Cardiol1995257167316807759722
   PubMed Web of Science ®Google Scholar
• FrommMFKimRBSteinCMWilkinsonGRRodenDMInhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidineCirculation19999945525579927403
   PubMed Web of Science ®Google Scholar
• ConnollySJCammAJHalperinJLDronedarone in high-risk permanent atrial fibrillationN Engl J Med2011365242268227622082198
   PubMed Web of Science ®Google Scholar
• HohnloserSHHalperinJLCammAJGaoPRadzikDConnollySJPALLAS investigatorsInteraction between digoxin and dronedarone in the PALLAS trialCirc Arrhythm Electrophysiol2014761019102525378467
   PubMed Web of Science ®Google Scholar
• JacobSSellkeFIs bicaval orthotopic heart transplantation superior to the biatrial technique?Interact Cardiovasc Thorac Surg20099233334219429638
   PubMedGoogle Scholar
• GasparovaIKubatkaPOpatrilovaRPerspectives and challenges of antioxidant therapy for atrial fibrillationNaunyn Schmiedebergs Arch Pharmacol20173901114
   PubMed Web of Science ®Google Scholar
• RobieuxIDorianPKleinJThe effects of cardiac transplantation and cyclosporine therapy on digoxin pharmacokineticsJ Clin Pharmacol19923243383431569236
   PubMed Web of Science ®Google Scholar